# Epoetin beta

## Recormon inj 2000IU(限洗腎室用)

| 藥物代碼           | IRECB                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Treatment of anaemia associated w/ chronic renal failure (CRF) in patients on dialysis; treatment of symptomatic renal anaemia in patient not yet undergoing dialysis. Treatment of symptomatic anaemia in adult patients w/ non-myeloid malignancies receving chemotherapy. Increasing the yield of autologous blood from patients in pre-donation programmes. Prevention of anaemia in premature infant (<34 wk; 750-1,500 g birth wt). |
| 副作用             | Increased BP, increased platelet count, encephalopathy-like symptoms, thromboembolic event, rash, pruritus, urticaria or inj site reactions.                                                                                                                                                                                                                                                                                              |
| 禁忌               | Hypersensitivity. Poorly controlled HTN. Patients, who in the mth preceding treatment, have suffered a MI or stroke. Unstable angina pectoris. Patients at risk of DVT.                                                                                                                                                                                                                                                                   |
| 藥物保存方式       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 用法用量           | Anaemia w/ CRF: Correction phase SC inj Initially, 3 x 20 IU/kg/wk, may be increased every 4 wk by 3 x 20 IU/kg/wk if the increase of packed cell vol (PCV) is inadequate (<0.5% per wk). Prevention of anaemia of prematurity SC inj 3 x 250 IU/kg/wk for 6 wk.                                                                                                                                                                          |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 哺乳期用藥建議     | Contraindicated 哺乳期使用禁忌                                                                                                                                                                                                                                                                                                                                                                                                            |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 注射劑給藥建議途徑 | IVD, IVP, IVPUSH, SC                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IVP 用法建議       | 注射藥劑的時間要大於兩分鐘，血液透析病人可以在洗腎結束時經由動-靜脈婁管進行注射。                                                                                                                                                                                                                                                                                                                                                         |
| IVD 用法建議       | 靜脈注射時，注射藥劑的時間要大於兩分鐘，血液透析病人可以在洗腎結束時經由動-靜脈婁管進行注射。                                                                                                                                                                                                                                                                                                                                             |
| 注意事項           | 1.在沒有相容性研究的情況下，本品不可與其它藥物混合使用。 2.配製好溶液可以經由皮下或是靜脈注射使用。當使用靜脈注射時，注射藥劑的時間要大於兩分鐘，譬如說，血液透析病人可以在洗腎結束時經由動-靜脈婁管進行注射。                                                                                                                                                                                                                            |

